Biogen (NASDAQ:BIIB – Get Free Report) and BioNTech (NASDAQ:BNTX – Get Free Report) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Analyst Ratings This is a summary of current ratings […]
Allspring Global Investments Holdings LLC grew its position in Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 278.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,408 shares of the biopharmaceutical company’s stock after acquiring an additional 34,157 shares during the period. Allspring Global […]
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its price objective trimmed by HC Wainwright from $5.00 to $3.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q4 2023 earnings at ($0.24) EPS, FY2023 […]